NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.30% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.20% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.16% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.13% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.90% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.81% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.80% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.80% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.74% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.74% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.71% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.70% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.65% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.61% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.60% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.55% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.43% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.38% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.37% |